ReferenceO raku jetre


1. Liver Cancer/ Nexavar Document. 2008.
2. Thuluvath PJ, Choti M, Geschwind JF, Norwitz L and Kalloo AN. About Liver Cancer. Johns Hopkins Liver Cancer Center.
3. Guyton A and Hall J. The Liver as an Organ. Chapter 70. In: Textbook of Medical Physiology. 10th edition. Philadelphia 
4. Reinus J. Hepatic Struocture and Function. Section 5. In: Brandt L. Clinical Practice of Gastroenterology. Volume 2. Philadelphia: Current Medicine Inc., 1999.
5. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340: 745 - 750
6. Available at American Society of Clinical Oncology: 
7. Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress, Lyon, 2004. Available at: Accessed May 2008.
8. Forner A, Hessheimer AJ, Isabel Real M, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2006; 60: 89 - 98.
9. Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005; 11: 7391 - 400
10. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 2006 Dec 7; 12 (45): 7239 - 49.
11. Available at Mayo Clinic:
12. Hall AJ and Wild CP. Liver cancer in low and middle income countries. BMJ 2003; 326; 994-995.
13. Available at Centers for Disease Control and Prevention (CDC):
14. Tanaka Y, Hanada K, Mizokami M, et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002; 99: 15584 - 15589.
15. Giordano TP, Kramer JR, Souchek J, Richardson P, El Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992 - 2001. Arch Intern Med 2004; 164: 2349 - 2354.
16. Qian Y, Fan JG. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int. 2005; 4(2): 173 - 177.
17. Available at Mayo Clinic:
18 Davila, JA, Morgan, RO. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. GUT . 2005;54:533-539. Available at:
19. Veldt, B., Chen, W. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008; 1856 - 1862.
20. Bruix J and Sherman M. Management of Hepatocellular carcinoma. Hepatology 2005; 42: 1208 - 36.
21. Ghassan AA. Hepatocellular Carcinoma: Molecular Biology and Therapy. Semin Oncol 2006; 33 (6 Suppl 11): S79 - S83.
22. Available at: National Cancer Institute:
23. American Liver Foundation "Debunking Liver Disease Myths." Last updated October 24, 2007. Available at:
24. American Liver Foundation Web site. Available at: http://www.liverfoundation/org/education/info/progression/
25. WebMd. Available at:
26. Available at the American Liver Foundation: